Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Loubser

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Plants (Basel, Switzerland)|August 14, 2020
The Application of a Commercially Available Citrus-Based Extract Mitigates Moderate NaCl-Stress in <i>Arabidopsis thaliana</i> PlantsJohannes Loubser, Paul Hills
Scientific Reports|April 30, 2024
Droplet based whole genome amplification for sequencing minute amounts of purified Mycobacterium tuberculosis DNAAnzaan Dippenaar, Nabila Ismail, Tim H Heupink, et al.
Microorganisms|December 31, 2025
MTBseq-nf: Enabling Scalable Tuberculosis Genomics "Big Data" Analysis Through a User-Friendly Nextflow Wrapper for MTBseq PipelineAbhinav Sharma, Davi Josué Marcon, Johannes Loubser, et al.
Scientific Reports|September 11, 2025
Correction: Assessing the propensity of TB clinical isolates to form viable but non-replicating subpopulationsJulian L Coetzee, Nastassja L Kriel, Johannes Loubser, et al.
Scientific Reports|November 12, 2024
Assessing the propensity of TB clinical isolates to form viable but non-replicating subpopulationsJulian L Coetzee, Nastassja L Kriel, Johannes Loubser, et al.
Journal of Visualized Experiments : Jove|September 15, 2025
Amplicon Sequencing using the Long-Read Sequencing TechnologiesMorwasehla Modjadji, Brendon Coenrad Mann, Johannes Loubser, et al.
Frontiers in Cellular and Infection Microbiology|September 22, 2025
Population structure and emergence of resistance to new and repurposed drugs in XDR-TB: insights from a 10-year genomic study in the Western Cape, South Africa reviewJustice Tresor Ngom, Johannes Loubser, Elizna Maasdorp, et al.
Plos One|June 6, 2024
Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistryAnzaan Dippenaar, Emilyn Costa Conceição, Felicia Wells, et al.
Scientific Reports|June 6, 2023
Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutationsChristian C Otum, Emmanuel Rivière, Monique Barnard, et al.
Journal of Global Antimicrobial Resistance|December 14, 2025
Undetected rifampicin-resistant tuberculosis associated with rpoB I491F and V170F mutations in Botswana: Diagnostic implicationsTuelo Mogashoa, Justice T Ngom, Johannes Loubser, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Plants (Basel, Switzerland)|August 14, 2020
The Application of a Commercially Available Citrus-Based Extract Mitigates Moderate NaCl-Stress in <i>Arabidopsis thaliana</i> PlantsJohannes Loubser, Paul Hills
Scientific Reports|April 30, 2024
Droplet based whole genome amplification for sequencing minute amounts of purified Mycobacterium tuberculosis DNAAnzaan Dippenaar, Nabila Ismail, Tim H Heupink, et al.
Microorganisms|December 31, 2025
MTBseq-nf: Enabling Scalable Tuberculosis Genomics "Big Data" Analysis Through a User-Friendly Nextflow Wrapper for MTBseq PipelineAbhinav Sharma, Davi Josué Marcon, Johannes Loubser, et al.
Scientific Reports|September 11, 2025
Correction: Assessing the propensity of TB clinical isolates to form viable but non-replicating subpopulationsJulian L Coetzee, Nastassja L Kriel, Johannes Loubser, et al.
Scientific Reports|November 12, 2024
Assessing the propensity of TB clinical isolates to form viable but non-replicating subpopulationsJulian L Coetzee, Nastassja L Kriel, Johannes Loubser, et al.
Journal of Visualized Experiments : Jove|September 15, 2025
Amplicon Sequencing using the Long-Read Sequencing TechnologiesMorwasehla Modjadji, Brendon Coenrad Mann, Johannes Loubser, et al.
Frontiers in Cellular and Infection Microbiology|September 22, 2025
Population structure and emergence of resistance to new and repurposed drugs in XDR-TB: insights from a 10-year genomic study in the Western Cape, South Africa reviewJustice Tresor Ngom, Johannes Loubser, Elizna Maasdorp, et al.
Plos One|June 6, 2024
Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistryAnzaan Dippenaar, Emilyn Costa Conceição, Felicia Wells, et al.
Scientific Reports|June 6, 2023
Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutationsChristian C Otum, Emmanuel Rivière, Monique Barnard, et al.
Journal of Global Antimicrobial Resistance|December 14, 2025
Undetected rifampicin-resistant tuberculosis associated with rpoB I491F and V170F mutations in Botswana: Diagnostic implicationsTuelo Mogashoa, Justice T Ngom, Johannes Loubser, et al.
Pageof 3